Scolaris Content Display Scolaris Content Display

Modified dietary fat intake for treatment of gallstone disease

This is not the most recent version

References

Additional references

Aune 2016

Aune D, Vatten LJ. Diabetes mellitus and the risk of gallbladder disease: a systematic review and meta‐analysis of prospective studies. Journal of Diabetes and Its Complications 2016;30(2):368‐73.

Behar 1989

Behar J, Lee KY, Thompson WR, Biancani P. Gallbladder contraction in patients with pigment and cholesterol stones. Gastroenterology 1989;97(6):1479‐84. [PUBMED: 2583414]

British Liver Trust 2011

British Liver Trust. Gallstones. www.britishlivertrust.org.uk/liver‐information/liver‐conditions/gallstones/ (accessed 2 April 2016).

Brok 2008

Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta‐analyses. Journal of Clinical Epidemiology 2008;61(8):763‐9. [PUBMED: 20042080]

Brok 2009

Brok J, Thorlund K, Wetterslev J, Gluud C. Apparently conclusive meta‐analyses may be inconclusive — Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta‐analyses. International Journal of Epidemiology 2009;38(1):287‐98.

BUPA 2015

BUPA. Gallstones. www.bupa.co.uk/individuals/health‐information/directory/g/gallstones#textBlock206155 (accessed 2 April 2016).

CHBG 2014

Cochrane Hepato‐Biliary Group. Data collection form for intervention reviews for randomised clinical trials only. hbg.cochrane.org/forms‐and‐documents (accessed 12 July 2016).

Demets 1987

Demets DL. Methods for combining randomized clinical trials: strengths and limitations. Statistics in Medicine 1987;6(3):341‐50.

DerSimonian 1986

DerSimonian R, Laird N. Meta‐analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177‐88.

EASL 2016

European Association for the Study of Liver Disease (EASL). EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones. Journal of Hepatology2016; Vol. 65, issue 1:146‐81.

Festi 2000

Festi D, Colecchia A, Larocca A, Villanova N, Mazzella G, Petroni ML, et al. Review: low caloric intake and gall‐bladder motor function. Alimentary Pharmacology & Therapeutics 2000;14(Suppl 2):51‐3. [PUBMED: 10903004 ]

Ganji 1994

Ganji V, Kies CV. Psyllium husk fibre supplementation to soybean and coconut oil diets of humans: effect on fat digestibility and faecal fatty acid excretion. European Journal of Clinical Nutrition 1994;48(8):595‐7.

Gluud 2017

Gluud C, Nikolova D, Klingenberg SL. Cochrane Hepato‐Biliary Group. About Cochrane 2017, Issue 2. Art. No.: LIVER.

GRADEpro GDT [Computer program]

Grade Working Group, McMaster University. GRADEpro GDT. Version accessed prior to 10 March 2017. Hamilton (ON): Grade Working Group, McMaster University, 2014.

Greenland 2016

Greenland S, Mansournia MA, Altman DG. Sparse data bias: a problem hiding in plain sight. BMJ (Clinical Research Ed.) 2016;352:i1981.

Halldestam 2004

Halldestam I, Enell EL, Kullman E, Borch K. Development of symptoms and complications in individuals with asymptomatic gallstones. British Journal of Surgery 2004;91(6):734‐8. [PUBMED: 15164444]

Higgins 2002

Higgins JP, Thompson SG. Quantifying heterogeneity in a meta‐analysis. Statistics in Medicine 2002;21(11):1539‐58.

Higgins 2003

Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analyses. BMJ (Clinical Research Ed.) 2003;327(7414):557‐60.

Higgins 2011

Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org.

Hopman 1985

Hopman WP, Jansen JB, Lamers CB. Comparative study of the effects of equal amounts of fat, protein, and starch on plasma cholecystokinin in man. Scandinavian Journal of Gastroenterology 1985;20(7):843‐7. [PUBMED: 4048835]

Hopman 1987

Hopman WP, Jansen JB, Rosenbusch G, Lamers CB. Cephalic stimulation of gallbladder contraction in humans: role of cholecystokinin and the cholinergic system. Digestion 1987;38(4):197‐203. [PUBMED: 3447914]

ICH‐GCP 1997

International Conference on Harmonisation Expert Working Group. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice CFR & ICH Guidelines. Vol. 1, Philadelphia (PA): Barnett International/PAREXEL, 1997.

Jakobsen 2014

Jakobsen J, Wetterslev J, Winkel P, Lange T, Gluud C. Thresholds for statistical and clinical significance in systematic reviews with meta‐analytic methods. BMC Medical Research Methodology 2014;14:120.

Keus 2006

Keus F, de Jong JA, Gooszen HG. Laparoscopic versus open cholecystectomy for patients with symptomatic cholecystolithiasis. Cochrane Database of Systematic Reviews 2006, Issue 4. [DOI: 10.1002/14651858.CD006231]

Kjaergard 2001

Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta‐analyses. Annals of Internal Medicine 2001;135(11):982‐9.

Lecerf 2011

Lecerf JM, Lorgeril M. Dietary cholesterol: from physiology to cardiovascular risk. British Journal of Nutrition 2011;106(1):6‐14.

Lundh 2012

Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L. Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews 2012, Issue 12. [DOI: 10.1002/14651858.MR000033.pub2]

Madden 1992

Madden A. The role of low fat diets in the management of gall‐bladder disease. Journal of Human Nutrition and Dietetics 1992;5:267‐73. [DOI: 10.1111/j.1365‐277X.1992.tb00165.x]

Mantel 1959

Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute 1959;22:719‐48.

May 1993

May GR, Sutherland LK, Shaffer EA. Efficacy of bile acid therapy for gallstone dissolution: a meta‐analysis of randomized trials. Alimentary Pharmacology and Therapeutics 1993;7(2):139‐48.

Meader 2014

Meader N, King K, Llewellyn A, Norman G, Brown J, Rodgers M, et al. A checklist designed to aid consistency and reproducibility of GRADE assessments: development and pilot validation. Systematic Reviews 2014;3(82):1‐9.

Mendez‐Sanchez 2007

Mendez‐Sanchez N, Zamora‐Valdes D, Chavez‐Tapia NC, Uribe M. Role of diet in cholesterol gallstone formation. Clinica Chimica Acta 2007;376(1‐2):1‐8. [PUBMED: 17055469]

Mogadam 1984

Mogadam M, Albarelli J, Ahmed SW, Grogan EJ, Mascatello VJ. Gallbladder dynamics in response to various meals: is dietary fat restriction necessary in the management of gallstones?. American Journal of Gastroenterology 1984;79(10):745‐7. [PUBMED: 6486112]

Moher 1998

Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta‐analyses?. Lancet 1998;352(9128):609‐13.

NICE 2014

National Institute of Health and Care Excellence. Gallstone disease: diagnosis and management of cholelithiasis, cholecystitis and choledocholithiasis. www.nice.org.uk/guidance/cg188/evidence/full‐guideline‐193302253 (accessed 2 April 2016).

Patient 2014

Patient. Gallstones diet sheet. patient.info/health/gallstones‐diet‐sheet (accessed 2 April 2016).

Radio 4 2012

Radio 4. Medical Matters. downloads.bbc.co.uk/podcasts/radio4/medmatters/medmatters_20120918‐2130a.mp3 (accessed 2 April 2016).

RevMan 5 2014 [Computer program]

The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.

Royle 2003

Royle P, Milne R. Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches. International Journal of Technology Assessment in Health Care 2003;19(4):591‐603.

Savovic 2012

Savovic J, Jones HE, Altman DG, Harris RJ, Jüni P, Pildal J, et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Health Technology Assessment 2012;16(35):1‐82.

Savovic 2012a

Savovic J, Jones HE, Altman DG, Harris RJ, Jüni P, Pildal J, et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Annals of Internal Medicine 2012;157(6):429‐38.

Schulz 1995

Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408‐12.

Scollay 2011

Scollay JM, Mullen R, McPhillips G, Thompson AM. Mortality associated with the treatment of gallstone disease: a 10‐year contemporary national experience. World Journal of Surgery 2011;35(3):643‐7. [PUBMED: 21181471]

Stinton 2010

Stinton LM, Myers RP, Shaffer EA. Epidemiology of gallstones. Gastroenterology Clinics of North America 2010;39(2):157‐69, vii. [PUBMED: 20478480]

Stokes 2014a

Stokes CS, Gluud LL, Casper M, Lammert F. Diets for primary prevention of gallbladder stones in adults. Cochrane Database of Systematic Reviews 2014, Issue 3. [DOI: 10.1002/14651858.CD009918.pub2]

Stokes 2014b

Stokes CS,  Gluud LL,  Casper M,  Lammert F. Ursodeoxycholic acid and diets higher in fat prevent gallbladder stones during weight loss: a meta‐analysis of randomized controlled trials. Clinical Gastroenterology and Hepatology 2014;12(7):1090‐100.

Theuwissen 2008

Theuwissen E, Mensink RP. Water‐soluble dietary fibers and cardiovascular disease. Physiology & Behavior 2008;94(2):285‐92.

Thorlund 2009

Thorlund K, Devereaux PJ, Wetterslev J, Guyatt G, Ioannidis JP, Thabane L, et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta‐analyses. International Journal of Epidemiology 2009;38(1):276‐86.

Thorlund 2010

Thorlund K, Anema A, Mills E. Interpreting meta‐analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV‐infected individuals. Clinical Epidemiology 2010;2:57‐66.

Thorlund 2011

Thorlund K, Engstrøm J, Wetterslev J, Brok J, Imberger G, Gluud C. User manual for Trial Sequential Analysis (TSA). ctu.dk/tsa/files/tsa_manual.pdf (accessed 25 April 2016).

TSA 2016 [Computer program]

Copenhagen Trial Unit. TSA ‐ Trial Sequential Analysis. Version 0.9.5.5 Beta. Copenhagen: Copenhagen Trial Unit, 2016.

Venneman 2010

Venneman NG, van Erpecum KJ. Pathogenesis of gallstones. Gastroenterology Clinics of North America 2010;39(2):171‐83, vii. [PUBMED: 20478481]

Wetterslev 2008

Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta‐analysis. Journal of Clinical Epidemiology 2008;61:64‐75. [PUBMED: 18083463]

Wetterslev 2009

Wetterslev J, Thorlund K, Brok J, Gluud C. Estimating required information size by quantifying diversity in random‐effects model meta‐analyses. BMC Medical Research Methodology 2009;9:86. [PUBMED: 20042080]

Wood 2008

Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman GD, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta‐epidemiological study. BMJ (Clinical Research Ed.) 2008;336:601‐5.